Skip to main content
. 2016 May 13;31(2):213–222. doi: 10.3803/EnM.2016.31.2.213

Table 3. Effect of Selenium Supplementation on TPO antibodies in Eight Randomized Clinical Trials.

Study Selenium preparation Outcome TPO-Ab On L-T4 No. of patients, placebo/selenium Baseline Se, µg/L Baseline TPO-Ab, kU/L
Gartner et al. (2002) [23] Selenite Fall Yes 34/36 69 904
Duntas et al. (2003) [24] SeMet Fall Yes 31/34 75 1,875
Turker et al. (2006) [25] SeMet Fall Yes 40/48 - 803
Karanikas et al. (2008) [26] Selenite No change Yes 18/18 75 524
Nacamulli et al. (2010) [27] Selenite No changea No 30/46 - 172
Eskes et al. (2014) [28] Selenite No change No 30/31 74 1,508
Pilli et al. (2015) [29] SeMet No change No 20/40 82 409
de Farias et al. (2015) [30] SeMet Fall Yes 27/28 37 1,009

TPO-Ab, thyroid peroxidase antibody; Se, selenium; Selenite, sodium selenite; SeMet, selenomethionine.

aFall at 1 year.

HHS Vulnerability Disclosure